<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Macular Degeneration &#187; Macugen</title>
	<atom:link href="http://www.curemaculardegeneration.com/tag/macugen/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.curemaculardegeneration.com</link>
	<description>Offers information on macular degeneration, or AMD, and also how to stop age related macular degeneration.</description>
	<lastBuildDate>Thu, 04 Mar 2010 23:00:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Carrot can help maintain your eye sights</title>
		<link>http://www.curemaculardegeneration.com/3465/carrot-can-help-maintain-your-eye-sights/</link>
		<comments>http://www.curemaculardegeneration.com/3465/carrot-can-help-maintain-your-eye-sights/#comments</comments>
		<pubDate>Mon, 13 Apr 2009 12:09:31 +0000</pubDate>
		<dc:creator>amitava</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Carrot]]></category>
		<category><![CDATA[Cause Of Blindness]]></category>
		<category><![CDATA[Eye Sights]]></category>
		<category><![CDATA[Leading Cause Of Blindness]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Sodium]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://dfba2d6e86a7c500535dad1f22113c10</guid>
		<description><![CDATA[October 8th, 2005 Age-related <b>macular degeneration</b> (AMD) is the leading cause of blindness in older patients in US and the developed world. Pegaptanib sodium (Macugen) is a new treatment for exudative AMD, and has been shown to <b>...</b>]]></description>
			<content:encoded><![CDATA[October 8th, 2005 Age-related <b>macular degeneration</b> (AMD) is the leading cause of blindness in older patients in US and the developed world. Pegaptanib sodium (Macugen) is a new treatment for exudative AMD, and has been shown to <b>...</b>]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/3465/carrot-can-help-maintain-your-eye-sights/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lucentis and Macugen Endorsed as Macular Degeneration  Treatments</title>
		<link>http://www.curemaculardegeneration.com/1904/lucentis-and-macugen-endorsed-as-macular-degeneration-treatments/</link>
		<comments>http://www.curemaculardegeneration.com/1904/lucentis-and-macugen-endorsed-as-macular-degeneration-treatments/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 05:00:00 +0000</pubDate>
		<dc:creator>Barry Wheeler</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Academy Of Ophthalmology]]></category>
		<category><![CDATA[American Academy Of Ophthalmology]]></category>
		<category><![CDATA[Avastin]]></category>
		<category><![CDATA[Endorsement]]></category>
		<category><![CDATA[Literature]]></category>
		<category><![CDATA[Lucentis]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>

		<guid isPermaLink="false">http://www.amdsupport.ca/articles/312/1/Lucentis-and-Macugen-Endorsed-as-Macular-Degeneration--Treatments/Page1.html</guid>
		<description><![CDATA[After a comprehensive review of the scientific literature available, Lucentis and Macugen have been endorsed by the American Academy of Ophthalmology as safe and effective treatments for macular degeneration for up to 2 years.&#160; In the endorsement it was indicated that there is evidence to support that Macugen and Lucentis as effective treatments.&#160; However, there was no endorsement given for Avastin as a treatment for macular degeneration at this time.]]></description>
			<content:encoded><![CDATA[After a comprehensive review of the scientific literature available, Lucentis and Macugen have been endorsed by the American Academy of Ophthalmology as safe and effective treatments for macular degeneration for up to 2 years.&nbsp; In the endorsement it was indicated that there is evidence to support that Macugen and Lucentis as effective treatments.&nbsp; However, there was no endorsement given for Avastin as a treatment for macular degeneration at this time.]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/1904/lucentis-and-macugen-endorsed-as-macular-degeneration-treatments/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Boston&#039;s Patriots: What to look forward to in &quot;Medical care by Obama&quot;</title>
		<link>http://www.curemaculardegeneration.com/6853/bostons-patriots-what-to-look-forward-to-in-medical-care-by-obama/</link>
		<comments>http://www.curemaculardegeneration.com/6853/bostons-patriots-what-to-look-forward-to-in-medical-care-by-obama/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>Bishop Seabury, 5th CT Regiment</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Boston Patriots]]></category>
		<category><![CDATA[Cause Of Blindness]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Limited]]></category>
		<category><![CDATA[Lucentis]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medical Care]]></category>
		<category><![CDATA[Restricted Access]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://47cac811f4320854c8cc9b446b077070</guid>
		<description><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></description>
			<content:encoded><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/6853/bostons-patriots-what-to-look-forward-to-in-medical-care-by-obama/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Amateur Economist: Healthcare Rationing, Administrative Costs, and &#8230;</title>
		<link>http://www.curemaculardegeneration.com/6886/amateur-economist-healthcare-rationing-administrative-costs-and/</link>
		<comments>http://www.curemaculardegeneration.com/6886/amateur-economist-healthcare-rationing-administrative-costs-and/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>Speedmaster</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Administrative Costs]]></category>
		<category><![CDATA[Amateur]]></category>
		<category><![CDATA[Cause Of Blindness]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[Healthcare Costs]]></category>
		<category><![CDATA[Healthcare Rationing]]></category>
		<category><![CDATA[Lucentis]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Nice Men]]></category>
		<category><![CDATA[Restricted Access]]></category>
		<category><![CDATA[Wsj]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://6055350042ff8546221da0bcd2191ead</guid>
		<description><![CDATA[Of NICE and Men - WSJ.com: "In  2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of ...]]></description>
			<content:encoded><![CDATA[Of NICE and Men - WSJ.com: "In  2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/6886/amateur-economist-healthcare-rationing-administrative-costs-and/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Gray Area: The Reality Behind the Talk of Reducing Health Care &#8230;</title>
		<link>http://www.curemaculardegeneration.com/6926/the-gray-area-the-reality-behind-the-talk-of-reducing-health-care/</link>
		<comments>http://www.curemaculardegeneration.com/6926/the-gray-area-the-reality-behind-the-talk-of-reducing-health-care/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>MSK</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Cause Of Blindness]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Gray Area]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Lucentis]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Reducing Health]]></category>
		<category><![CDATA[Restricted Access]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://104ebcc0e424159476f461f8ccfbc387</guid>
		<description><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></description>
			<content:encoded><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/6926/the-gray-area-the-reality-behind-the-talk-of-reducing-health-care/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>There&#039;s My Two Cents: How Much Is Your Life Worth?</title>
		<link>http://www.curemaculardegeneration.com/7282/theres-my-two-cents-how-much-is-your-life-worth/</link>
		<comments>http://www.curemaculardegeneration.com/7282/theres-my-two-cents-how-much-is-your-life-worth/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>2Cents</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Cause Of Blindness]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Lucentis]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Restricted Access]]></category>
		<category><![CDATA[Two Cents]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://1bdfa01826ff922cdacb1d481ac505f1</guid>
		<description><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></description>
			<content:encoded><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/7282/theres-my-two-cents-how-much-is-your-life-worth/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Plumb Bob Blog » Death Panels Already Exist</title>
		<link>http://www.curemaculardegeneration.com/8224/plumb-bob-blog-%c2%bb-death-panels-already-exist/</link>
		<comments>http://www.curemaculardegeneration.com/8224/plumb-bob-blog-%c2%bb-death-panels-already-exist/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>unknown</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Cause Of Blindness]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Lucentis]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Plumb Bob]]></category>
		<category><![CDATA[Restricted Access]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://c2190779eaec47d158a354d2b8f833ea</guid>
		<description><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></description>
			<content:encoded><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/8224/plumb-bob-blog-%c2%bb-death-panels-already-exist/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How do u pay 2/3 of costs of covering 10s of millions more people &#8230;</title>
		<link>http://www.curemaculardegeneration.com/11456/how-do-u-pay-23-of-costs-of-covering-10s-of-millions-more-people/</link>
		<comments>http://www.curemaculardegeneration.com/11456/how-do-u-pay-23-of-costs-of-covering-10s-of-millions-more-people/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[10s]]></category>
		<category><![CDATA[Cause Of Blindness]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Lucentis]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[People]]></category>
		<category><![CDATA[Restricted Access]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://796cec54e8fb81ac336c88168c3bf102</guid>
		<description><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></description>
			<content:encoded><![CDATA[In 2007, the board restricted access to two drugs for <b>macular degeneration</b>, a cause of blindness. The drug Macugen was  blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/11456/how-do-u-pay-23-of-costs-of-covering-10s-of-millions-more-people/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World Pharma News &#8211; Phase 3 Study Showed MACUGEN® Improved Vision &#8230;</title>
		<link>http://www.curemaculardegeneration.com/12660/world-pharma-news-phase-3-study-showed-macugen%c2%ae-improved-vision/</link>
		<comments>http://www.curemaculardegeneration.com/12660/world-pharma-news-phase-3-study-showed-macugen%c2%ae-improved-vision/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>unknown</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Adverse Events]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Clinical Experience]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Diabetic Macular Edema]]></category>
		<category><![CDATA[Improved Vision]]></category>
		<category><![CDATA[Macugen]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Pharma News]]></category>
		<category><![CDATA[Phase 3]]></category>
		<category><![CDATA[Wet Amd]]></category>
		<category><![CDATA[World News]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://c3cfe2f972ef48e5d7f4e67d28b64692</guid>
		<description><![CDATA[Adverse events were consistent with those observed in clinical trials of MACUGEN in patients with neovascular agerelated <b>macular degeneration</b> (wet AMD) and similar to clinical experience with MACUGEN. About Diabetic Macular Edema (DME) ...]]></description>
			<content:encoded><![CDATA[Adverse events were consistent with those observed in clinical trials of MACUGEN in patients with neovascular agerelated <b>macular degeneration</b> (wet AMD) and similar to clinical experience with MACUGEN. About Diabetic Macular Edema (DME) ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/12660/world-pharma-news-phase-3-study-showed-macugen%c2%ae-improved-vision/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
